New insights in intravesical treatment for intermediate- and high-risk non-muscle-invasive urothelial bladder carcinoma

Editorial

Marko Babjuk. Eur Urol. 2010 May.

. 2010 May;57(5):774-6; author reply 776-7.

doi: 10.1016/j.eururo.2010.01.004. Epub 2010 Jan 14.

No abstract available

Comment on

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder.
Sylvester RJ, Brausi MA, Kirkels WJ, Hoeltl W, Calais Da Silva F, Powell PH, Prescott S, Kirkali Z, van de Beek C, Gorlia T, de Reijke TM; EORTC Genito-Urinary Tract Cancer Group. Sylvester RJ, et al. Eur Urol. 2010 May;57(5):766-73. doi: 10.1016/j.eururo.2009.12.024. Epub 2009 Dec 18. Eur Urol. 2010. PMID: 20034729 Free PMC article. Clinical Trial.